MX2021003668A - Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. - Google Patents
Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar.Info
- Publication number
- MX2021003668A MX2021003668A MX2021003668A MX2021003668A MX2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- depression
- sequences
- administration
- days
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title abstract 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003299 ketamine Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002685 pulmonary effect Effects 0.000 title abstract 2
- 230000002045 lasting effect Effects 0.000 abstract 2
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18461615.9A EP3628313B1 (en) | 2018-09-28 | 2018-09-28 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
| PCT/EP2019/075735 WO2020064748A1 (en) | 2018-09-28 | 2019-09-24 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021003668A true MX2021003668A (es) | 2021-08-19 |
Family
ID=63713806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021003668A MX2021003668A (es) | 2018-09-28 | 2019-09-24 | Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11925607B2 (https=) |
| EP (3) | EP3628313B1 (https=) |
| JP (1) | JP7444864B2 (https=) |
| KR (1) | KR102867739B1 (https=) |
| CN (1) | CN113038941A (https=) |
| AU (1) | AU2019349624B2 (https=) |
| BR (1) | BR112021005687A2 (https=) |
| CA (1) | CA3114325A1 (https=) |
| EA (1) | EA202190724A1 (https=) |
| ES (2) | ES3021221T3 (https=) |
| HU (2) | HUE071303T2 (https=) |
| MX (1) | MX2021003668A (https=) |
| PL (2) | PL3628313T3 (https=) |
| WO (1) | WO2020064748A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3505157T3 (pl) | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| GB0523031D0 (en) * | 2005-11-11 | 2005-12-21 | Yaupon Therapeutics | Enhancement of morphine analgesia by s(-)-norketamine |
| WO2007111880A2 (en) | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| DE102007009888A1 (de) | 2007-02-28 | 2008-09-04 | Hermann, Holger Lars, Dr. | Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| PE20141906A1 (es) | 2012-03-12 | 2014-12-05 | Janssen Pharmaceutica Nv | Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento |
| WO2014020155A1 (en) | 2012-08-02 | 2014-02-06 | Clinpharm Reform Gmbh | Oral transmucosal adminstration forms of s-ketamine |
| PE20200404A1 (es) | 2013-03-15 | 2020-02-26 | Janssen Pharmaceutica Nv | Composicion farmaceutica de clorhidrato de s-ketamina |
| CN116251084A (zh) | 2013-03-15 | 2023-06-13 | 詹森药业有限公司 | S-盐酸氯胺酮的药物组合物 |
| CN106714789A (zh) * | 2014-08-13 | 2017-05-24 | 詹森药业有限公司 | 用于治疗抑郁症的方法 |
| US20160338977A1 (en) * | 2015-05-20 | 2016-11-24 | Janssen Pharmaceutica Nv | Methods and kits for treating depression |
| CN106562952B (zh) * | 2015-10-09 | 2020-06-09 | 江阴安博生物医药有限公司 | 氯胺酮在治疗重性抑郁障碍中的应用 |
| PL3505157T3 (pl) * | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
-
2018
- 2018-09-28 EP EP18461615.9A patent/EP3628313B1/en active Active
- 2018-09-28 ES ES18461615T patent/ES3021221T3/es active Active
- 2018-09-28 PL PL18461615.9T patent/PL3628313T3/pl unknown
- 2018-09-28 HU HUE18461615A patent/HUE071303T2/hu unknown
-
2019
- 2019-09-24 EA EA202190724A patent/EA202190724A1/ru unknown
- 2019-09-24 PL PL19770131.1T patent/PL3856159T3/pl unknown
- 2019-09-24 US US17/281,136 patent/US11925607B2/en active Active
- 2019-09-24 BR BR112021005687-4A patent/BR112021005687A2/pt unknown
- 2019-09-24 EP EP19770131.1A patent/EP3856159B1/en active Active
- 2019-09-24 EP EP25162744.4A patent/EP4578505A3/en active Pending
- 2019-09-24 CA CA3114325A patent/CA3114325A1/en active Pending
- 2019-09-24 CN CN201980075601.XA patent/CN113038941A/zh active Pending
- 2019-09-24 ES ES19770131T patent/ES3028459T3/es active Active
- 2019-09-24 WO PCT/EP2019/075735 patent/WO2020064748A1/en not_active Ceased
- 2019-09-24 JP JP2021517252A patent/JP7444864B2/ja active Active
- 2019-09-24 MX MX2021003668A patent/MX2021003668A/es unknown
- 2019-09-24 KR KR1020217011554A patent/KR102867739B1/ko active Active
- 2019-09-24 HU HUE19770131A patent/HUE071649T2/hu unknown
- 2019-09-24 AU AU2019349624A patent/AU2019349624B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3628313T3 (pl) | 2025-06-23 |
| JP2022502429A (ja) | 2022-01-11 |
| HUE071649T2 (hu) | 2025-09-28 |
| EP3628313A1 (en) | 2020-04-01 |
| EP3856159A1 (en) | 2021-08-04 |
| EP4578505A3 (en) | 2025-09-03 |
| US11925607B2 (en) | 2024-03-12 |
| EP3856159B1 (en) | 2025-03-12 |
| ES3021221T3 (en) | 2025-05-26 |
| EA202190724A1 (ru) | 2021-08-18 |
| KR20210068465A (ko) | 2021-06-09 |
| HUE071303T2 (hu) | 2025-08-28 |
| AU2019349624B2 (en) | 2025-08-28 |
| PL3856159T3 (pl) | 2025-06-16 |
| EP3856159C0 (en) | 2025-03-12 |
| US20210353560A1 (en) | 2021-11-18 |
| BR112021005687A2 (pt) | 2021-06-22 |
| ES3028459T3 (en) | 2025-06-19 |
| EP3628313B1 (en) | 2025-02-12 |
| CA3114325A1 (en) | 2020-04-02 |
| EP4578505A2 (en) | 2025-07-02 |
| EP3628313C0 (en) | 2025-02-12 |
| JP7444864B2 (ja) | 2024-03-06 |
| KR102867739B1 (ko) | 2025-10-13 |
| WO2020064748A1 (en) | 2020-04-02 |
| AU2019349624A1 (en) | 2021-04-29 |
| CN113038941A (zh) | 2021-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202103404B (en) | Composition and method for treating the lungs | |
| ZA202204929B (en) | Rimegepant for cgrp related disorders | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| EA033113B1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| PH12020550237A1 (en) | Methods for the administration of certain vmat2 inhibitors | |
| MX2019006938A (es) | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. | |
| PH12021550302A1 (en) | Methods for the administration of certain vmat2 inhibitors | |
| JP2012180381A5 (https=) | ||
| RU2018113460A (ru) | Вдыхаемые никотиновые композиции и способы их получения и применения | |
| MX384843B (es) | Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas. | |
| MX377175B (es) | Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc). | |
| ZA202000028B (en) | Use of vibegron to treat overactive bladder | |
| JP2016539122A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| MX2021003668A (es) | Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. | |
| MX2017002476A (es) | Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matriz extracelular. | |
| JP2019529569A5 (https=) | ||
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
| MX2020010977A (es) | Procedimientos de tratamiento de infecciones fúngicas. | |
| JP2017530142A5 (https=) | ||
| EA202090416A1 (ru) | Способы лечения симптомов гастропареза с использованием велусетрага | |
| SG11201809042SA (en) | Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases | |
| MX2020011398A (es) | Metodos para tratar el sindrome de dolor regional complejo (crps) o sintomas que comprenden la administracion de acido neridronico. | |
| MX2023013983A (es) | Metodo de tratamiento del temblor esencial. |